Pharmasgp Holding SE Stock
Price
Target price
€22.20
€22.20
0.910%
0.2
0.910%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pharmasgp Holding SE Stock
Pharmasgp Holding SE gained 0.910% compared to yesterday.
Pros and Cons of Pharmasgp Holding SE in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
systinvest bought the security Pharmasgp Holding SE in his wikifolio Aktienwertselektion mit System.
Show more
News
![EQS-News: PharmaSGP Holding SE: Annual General Meeting approves full distribution of the Group’s profit for 2023 following a successful business performance](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
EQS-News: PharmaSGP Holding SE: Annual General Meeting approves full distribution of the Group’s profit for 2023 following a successful business performance
EQS-News: PharmaSGP Holding SE: Annual General Meeting approves full distribution of the Group’s profit for 2023 following a successful business performance
![EQS-News: PharmaSGP Holding SE strengthens the Management Board to further accelerate growth](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
EQS-News: PharmaSGP Holding SE strengthens the Management Board to further accelerate growth
EQS-News: PharmaSGP Holding SE strengthens the Management Board to further accelerate growth
![EQS-News: PharmaSGP continues dynamic business development with significant revenues growth in Q1 2024](/assets/news/news11-1ebbf8540812dc8f080ecfeb67ce19c492651a7c439bd800cec2630c3a04a840.png)
EQS-News: PharmaSGP continues dynamic business development with significant revenues growth in Q1 2024
EQS-News: PharmaSGP continues dynamic business development with significant revenues growth in Q1 2024